Mycophenolate mofetil

Mycophenolate mofetil is a carboxylic ester resulting from the formal condensation between the carboxylic acid group of mycophenolic acid and the hydroxy group of 2-(morpholin-4-yl)ethanol. In the liver, it is metabolised to mycophenolic acid, an immunosuppressant for which it is a prodrug. It is widely used to prevent tissue rejection following organ transplants as well as for the treatment of certain autoimmune diseases. Among its listed roles, it functions as a immunosuppressive agent, a prodrug, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor and an anticoronaviral agent. It is a gamma-lactone, a member of phenols, an ether, a carboxylic ester and a tertiary amino compound. Functionally, it is related to mycophenolic acid and a 2-(morpholin-4-yl)ethanol. It is grouped under the following drug class(es): Immunosuppressants. Its therapeutic use is listed as antirheumatic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Myfenax, myclausen and Arzip. Its PubChem CID is 5281078.

CAS No 128794-94-5
Molecular Formula C23H31NO7
Molecular Weight 433.50 g/mol
Synonyms 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate

Frequently Asked Questions